Home Page / Exhibitors / toSense

toSense

New New products
San Diego, CA 92121-2139
Booth(s):  9900-99

About

toSenseTM has a novel body-worn sensor, CoVaTM Monitoring System 2, that easily captures medical grade vital signs, including heart rate, heart rate variability, respiration rate, skin temperature, posture, single-lead ECG, as well as complex hemodynamic parameters, including thoracic impedance, stroke volume and cardiac output all from one location on the body. CoVaTM 2 is FDA cleared for all of the above-mentioned parameters. Data is sent wirelessly from the Necklace to the cloud.

New Product/Service

CoVa Monitoring System

Press Releases

toSenseTM announced today that it has received a second FDA clearance for its wearable patient-monitoring system, CoVaTM Monitoring System 2 (CoVaTM 2). The new clearance is for measurements of stroke volume and cardiac output, which can be made at home or in medical clinics. The clearance also includes a mobile application that allows medical professionals to remotely view measurement data and single-lead ECG waveforms.  CoVaTM 2 builds on the FDA-cleared CoVaTM Monitoring System (CoVaTM 1), which measures thoracic impedance, heart rate, heart rate variability, respiration rate, skin temperature and posture.

Information collected by CoVaTM 2 provides medical insight into the status of patients suffering from chronic illnesses, such as congestive heart failure, chronic obstructive pulmonary disease, hypertension, and renal failure, as well as patients who have been recently discharged from the hospital. This additional supervision can help reduce the time patients spend in hospitals, either by decreasing readmissions or allowing early discharge.

Worn like a conventional necklace for just minutes each day, CoVaTM 2 measures bioimpedance and ECG waveforms, and from these calculates vital signs and hemodynamic parameters, as described above.  Several gateways, including Android-based tablets and cellular-based systems, forward information to the cloud.  The recently cleared clinical gateway allows medical professionals to view the data in real-time.

 “CoVaTM 2 is transformational in delivering high-acuity monitoring outside of the hospital.  The system gives clinicians remote access to important, actionable data” said Matt Banet, President and Chief Scientific Officer at toSense TM.  “ The system’s low price point allows universal access to a new, exciting wearable that could be a critical component of modern healthcare systems.”

For more information, please visit www.toSense.com.

About toSenseTM

toSenseTM develops novel, wearable sensors—for patients in both the home and medical clinics—that provide critical, medical-grade information to clinicians.  With this, patients can be effectively managed remotely, whether they are suffering from chronic illnesses, recently discharged from the hospital, or just waiting to see a clinician.  The company strives to provide measurements of all vital signs and several hemodynamic measurements from a single location on the chest.  

San Diego, CA – March 6th, 2018 – toSenseTM announced today that it recently received a second FDA clearance for its CoVaTM Monitoring System 2 (CoVaTM 2), which is now available for order.  CoVaTM 2 features a body-worn sensor, wireless gateway, and cloud-based system. The recent clearance covers new measurements of stroke volume and cardiac output, which can be made at home or in medical clinics, along with display of single-lead ECG waveforms on a mobile application. CoVaTM 2 is also FDA-cleared for measurements of thoracic impedance (a proxy for fluids in the chest), heart rate, heart rate variability, respiration rate, skin temperature and posture.

Information collected by CoVaTM 2 provides medical insight into the status of patients suffering from chronic illnesses, such as congestive heart failure, chronic obstructive pulmonary disease, hypertension, and renal failure. The comprehensive supervision it provides can also reduce the time patients spend in hospitals, either by decreasing readmissions or allowing early discharge.

Worn like a conventional necklace for just minutes each day, CoVaTM 2’s sensor measures bioimpedance and ECG waveforms, and from these calculates vital signs and hemodynamic parameters, as described above.  The sensor sends information to several gateways, which can display numerics and real-time waveforms before forwarding them to the cloud-based system.  This system, in turn, can integrate with 3rd-party providers.

“CoVaTM 2 is transformational in delivering high-acuity monitoring of both vital signs and sophisticated hemodynamic parameters outside of the hospital.  The system gives clinicians remote access to important, actionable data that extends beyond conventional wearable monitors, which are limited to ECG waveforms.  And its low price point and easy-to-use form factor allows universal access to a new, exciting wearable that could be a critical component of modern healthcare systems” said Matt Banet, President of toSense TM.

For more information, please visit www.toSense.com.

About toSenseTM

toSenseTM develops novel, wearable sensors—for patients in both the home and medical clinics—that provide critical, medical-grade information to clinicians.  With this, patients can be effectively managed remotely, whether they are suffering from chronic illnesses, recently discharged from the hospital, or just waiting to see a clinician.  The company strives to provide measurements of all vital signs and several hemodynamic measurements from a single location on the chest.  

Media Contact
Susan Pede

VP, Operations

(760) 525-8299

susan.pede@toSense.com

WHERE THE WORLD
CONNECTS FOR HEALTH